Medical Device News Magazine

PURPLESUN Battles the Invisible Enemy – COVID-19 – There is Light

Company in Partnership with Hackensack Meridian Health and Northwell Health Form a Private Sector Partnership to Provide FMUV Shadowless Delivery Light Decontamination Technology to Government Agencies

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

September 23, 2020

PURPLESUN Inc. is a technology company on a mission to transform healthcare and provide a sustainable impact for the healthiest environments. Amid the COVID-19 crisis, there is light.

PurpleSun designs and manufactures hospital-grade mechatronic systems that are user friendly and provide a special type of Focused Multivector Ultraviolet (FMUV) light technology, for the purpose of disinfection in 90 seconds.

The company uses proprietary FMUV – focused light energy to improve germicidal effectiveness and speed – to quickly kill off organisms, as proven by several top publications, including the American Journal of Infection Control.

After extensive electrical and ultraviolet light emission testing, including risk mitigation analysis, the PurpleSun E300 was certified to the Standard, IEC 61010-1, by Underwriters Laboratory. The E300 modular and mobile PurpleSun system can be used to treat equipment and rooms while people continue to work around the system safely.

With a community of innovative minds from top executives, clinicians and board members at Hackensack Meridian Health, Northwell Health, and PurpleSun — the trio collaborated to provide access to PurpleSun technology to government agencies in order to help protect the crew and pilots to maximize operational readiness of their no-fail mission criteria.

At Hackensack Meridian Health, a leading not-for-profit health care organization that is the most comprehensive and truly integrated health care network in New Jersey. “We’re proud to help our crew members protect against the common enemy, COVID-19,” said Robert C. Garrett, CEO of Hackensack Meridian Health. “PurpleSun was one of the first investments made through our innovative Bear’s Den incubator program. Now that we’re in the thick of this pandemic, the choice of such an innovative disinfection technology seems more prescient than ever.”

At Northwell Health is New York State’s largest health care provider. “PurpleSun has played an important role in our fight against COVID-19. When the call came to support this initiative, the team stepped up to make the partnership happen – yet another testament to the culture at Northern Westchester Hospital and Northwell Health. Northern Westchester Hospital, along with Staten Island University Hospital and Cohen Children’s Medical Center were the first hospitals to purchase and use PurpleSun in our efforts to enhance disinfection. Having purchased multiple devices, we were able and proud to extend the technology to the government to protect their pilots and crew during this time of crisis,” said Derek Anderson, Executive Director of Northern Westchester Hospital.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”